Healthcare and Life Sciences
Stenvall Skoeld has experience from of wide range of areas within China’s Healthcare and Life Sciences sector, including:
We advise our corporate clients on China related strategy and M&A. Our services include acquisition target search, strategic due diligence, competitive intelligence and strategies for selling to Chinese customers.
Our support to private equity investors includes due diligence, early ownership / “first 100-day” action plans, and fund / sector strategies.
To find out more about our work in the industry, please email Per Stenvall (email)
Relevant case studies: